Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mike M who wrote (3319)	11/21/2000 11:03:28 AM
From: StockDung	Read Replies (1) \| Respond to of 5582

Just remember the Junior Stock Player's Creed: ........"Buy on mystery -- sell on history." Is there room for everybody in the life-raft? a QUOTE FROM HISTORY businessweek.com "One stock that has drawn scant attention online--but has nonetheless moved up powerfully this year--is Quigley Corp. Its shares have climbed more than 1,000% this year, largely on the strength of a lozenge that is supposed to lessen the severity of cold symptoms. Enthusiasm over the ''Cold-Eeze'' zinc-based lozenge has sent Quigley shares zooming from as low as 5/8, where they were trading in early April, to a recent 16. Not surprisingly, Quigley has begun to get attention from short-sellers, who feel that the company's prospects have been overestimated by the market. They are betting that someday soon, the market in such high-flying stocks will emit a violent sneeze--and nobody will be around to say, ''gesundheit.'' businessweek.com